Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × Oxaliplatin × Clear all

NCT06839105 2025-05-31

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Phase 1 Recruiting

DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Colorectal Neoplasms

NCT02889666 2024-04-17

CCODG-NSCLC

Phase 1 Recruiting

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT00268151 2018-03-05

Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00356941 2017-11-29

Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00305786 2016-12-15

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01243775 2015-08-17

BELOXAN

Phase 2 Completed

33 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00240097 2014-11-27

Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)

Phase 2 Completed

30 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00145418 2014-06-30

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Phase 2 Terminated

15 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00406302 2014-04-29

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00251524 2012-05-11

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00923637 2009-06-18

Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00217282 2008-05-22

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00238849 2005-10-14

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung